Skip to Main Content


The size of a kidney and the total number of nephrons formed late in embryologic development depend on the degree to which the ureteric bud undergoes branching morphogenesis. Humans have between 225,000 and 900,000 nephrons in each kidney, a number that mathematically hinges on whether ureteric branching goes to completion or is terminated prematurely by one or two cycles. Although the signaling mechanisms regulating cycle number are incompletely understood, these final rounds of branching likely determine how well the kidney will adapt to the physiologic demands of blood pressure and body size, various environmental stresses, or unwanted inflammation leading to chronic renal failure.


One of the intriguing generalities regarding chronic renal failure is that residual nephrons hyperfunction to compensate for the loss of those nephrons succumbing to primary disease. This compensation depends on adaptive changes produced by renal hypertrophy and adjustments in tubuloglomerular feedback and glomerulotubular balance, as advanced in the intact nephron hypothesis by Neal Bricker in 1969. Some physiologic adaptations to nephron loss also produce unintended clinical consequences explained by Bricker's trade-off hypothesis in 1972, and eventually some adaptations accelerate the deterioration of residual nephrons, as described by Barry Brenner in his hyperfiltration hypothesis in 1982. These three important notions regarding chronic renal failure form a conceptual basis for understanding common pathophysiology leading to uremia.


When the initial complement of nephrons is reduced by a sentinel event, such as unilateral nephrectomy, the remaining kidney adapts by enlarging and increasing its glomerular filtration rate. If the kidneys were initially normal, the filtration rate usually returns to 80% of normal for two kidneys. The remaining kidney grows by compensatory renal hypertrophy with very little cellular proliferation. This unique event is accomplished by increasing the size of each cell along the nephron, which is accommodated by the elasticity or growth of interstitial spaces under the renal capsule. The mechanism of this compensatory renal hypertrophy is only partially understood; studies suggest roles for angiotensin II transactivation of heparin-binding epithelial growth factor, PI3K, and p27kip1, a cell cycle protein that prevents tubular cells exposed to angiotensin II from proliferating, and the mammalian target of rapamycin (mTOR), which mediates new protein synthesis.


Hyperfiltration during pregnancy or in humans born with one kidney or who lose one to trauma or transplantation generally produces no ill consequences. By contrast, experimental animals that undergo resection of 80% of their renal mass, or humans who have persistent injury that destroys a comparable amount of renal tissue, progress to end-stage disease (Fig. 278-1). Clearly, there is a critical amount of primary nephron loss that produces maladaptive deterioration in remaining nephrons. This maladaptive response is referred to clinically as renal progression, and the pathologic correlate of renal progression is the relentless advance of tubular atrophy and tissue fibrosis. The mechanism for this maladaptive response is the focus of intense investigation. A unified theory of renal progression is just starting to emerge, and ...

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.


About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessMedicine Full Site: One-Year Subscription

Connect to the full suite of AccessMedicine content and resources including more than 250 examination and procedural videos, patient safety modules, an extensive drug database, Q&A, Case Files, and more.

$995 USD
Buy Now

Pay Per View: Timed Access to all of AccessMedicine

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.